KRAZATI 200 mg/1
adagrasib · TABLET, COATED · Mirati Therapeutics, Inc
No Recall History
Plain English
KRAZATI is a tablet, coated containing adagrasib at 200 mg/1, taken oral. Manufactured by Mirati Therapeutics, Inc.
Key Facts
- Brand Name
- KRAZATI
- Generic Name
- adagrasib
- NDC Code (Product)
80739-812- Manufacturer
- Mirati Therapeutics, Inc
- Strength
- 200 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA216340
- Marketing Start
- 12/12/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is KRAZATI used for?
KRAZATI contains adagrasib. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is KRAZATI a controlled substance?
KRAZATI is not classified as a controlled substance by the DEA.
What is the generic name for KRAZATI?
The generic name for KRAZATI is adagrasib. There are no other listed brand versions of adagrasib.
What is the NDC code for KRAZATI 200 mg/1?
The NDC (National Drug Code) for KRAZATI 200 mg/1 is 80739-812, listed by Mirati Therapeutics, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)